研究・業績

業績

原著論文

英文

  • Early Initiation of Plasma Exchange Therapy for a Patient with Anti-MDA5 Autoantibody Positive Dermatomyositis Developing Rapidly Progressive Interstitial Lung Disease
    Sasaki N, Ishii A, Kurabayashi T, Sugiyama M, Izumi Y, Nakagome Y, Hirano K, Sasaki S, Kondo Y, Nogi S, Nishikawa A, Hosono Y, Yamada C, Sato S.
    Mod Rheumatol Case Rep. 2021;5(1):87-94.
  • Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients’ cohort
    Ueda-Hayakawa I, Fujimoto M, Sato S, Murakami A, Kawakami A, Mishima M, Seishima M, Suda T, Takehara K, Mimori T, Kuwana M.
    J Dermatol Sci. 2021 May 25;S0923-1811(21)00111-0. doi: 10.1016/j.jdermsci.2021.05.005. Online ahead of print.
  • 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease
    Kondoh Y, Makino S, Ogura T, Suda T, Tomioka H, Amano H, Anraku M, Enomoto N, Fujii T, Fujisawa T, Gono T, Harigai M, Ichiyasu H, Inoue Y, Johkoh T, Kameda H, Kataoka K, Katsumata Y, Kawaguchi Y, Kawakami A, Kitamura H, Kitamura N, Koga T, Kurasawa K, Nakamura Y, Nakashima R, Nishioka Y, Nishiyama O, Okamoto M, Sakai F, Sakamoto S, Sato S, Shimizu T, Takayanagi N, Takei R, Takemura T, Takeuchi T, Toyoda Y, Yamada H, Yamakawa H, Yamano Y, Yamasaki Y, Kuwana M.
    Respir Investig. 2021;59(6):709-740.
  • Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease
    Gono T, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Ikeda K, Kirino Y, Sugiyama Y, Tanino Y, Nunokawa T, Kaneko Y, Sato S, Asakawa K, Ukichi T, Kaieda S, Naniwa T, Okano Y, Kuwana M; the Multicenter Retrospective Cohort of Japanese Patients with Myositis-Associated ILD (JAMI) Investigators.
    Arthritis Rheumatol. 2021 Apr;73(4):677-686. doi: 10.1002/art.41566. Epub 2021 Feb 22. PMID: 33118321.

学会発表

国際

  • The management of anti-MDA5 antibody positive dermatomyositis and rapidly progressive interstitial lung disease
    Sato S.
    The 6th Renji Forum-Autoimmune Summit-Shanghai 2021. 2021.8
  • The clinical significance of anti-PC4 And SFRS1 Interacting Protein 1 antibody in polymyositis and dermatomyositis patients
    Hosono Y, Kojima A, Ishii A, Izumi Y, Hirano K, Sasaki N, Yamada C, Sato S.
    American College of Rheumatology Convergence 2021. 2021.11
  • Early Initiation of Plasma Exchange Therapy for a Patient with Anti-MDA5 Autoantibody Positive Dermatomyositis Developing Rapidly Progressive Interstitial Lung Disease
    Hirano K, Kojima A, Ishii A, Sugiyama M, Izumi Y, Sasaki N, Hosono Y, Yamada C, Sato S.
    American College of Rheumatology Convergence 2021. 2021.11

ページトップへ戻る